Download PDF
Thorac Cardiovasc Surg 2001; 49(3): 153-156
DOI: 10.1055/s-2001-14292
Original Cardiovascular
Original Paper
© Georg Thieme Verlag Stuttgart · New York

The Influence of the Duration of Cardiopulmonary Bypass on Coagulation, Fibrinolysis and Platelet Function

A. Wahba1 , G. Rothe2 , H. Lodes1 , S. Barlage2 , G. Schmitz2
  • 1Department of Cardiac, Thoracic, and Vascular Surgery (Klinik für Herz-, Thorax und herznahe Gefäßchirurgie
  • 2Department of Clinical Chemistry (Institut für Klinische Chemie und Laboratoriumsmedizin) Klinikum Regensburg, University of Regensburg, Germany
Further Information

Publication History

Publication Date:
31 December 2001 (online)

    Permissions and Reprints All articles of this category

Background: The duration of cardiopulmonary bypass (CPB) might influence blood coagulation. This appears particularly relevant in the light of new, less invasive techniques that propose smaller incisions at the expense of a possible prolongation of time on CPB. Methods: The time-dependent effects on coagulation, fibrinolysis and platelet function were investigated in 94 patients scheduled for elective coronary artery bypass grafting. Tests on coagulation, fibrinolysis, and platelet function (flow cytometric assay of expression densities of glycoprotein IIb/IIIa and P-selection were performed the day before surgery and after completion of surgery. Results: A significant correlation was found between the duration of CPB and parameters of increased coagulation, decrease of platelet counts during CPB and platelet function. Longer duration of CPB led to an increased need for transfusion of red blood cells. Conclusions: The duration of CPB affects thrombin formation as well as platelet count and function, but not the fibrinolytic system. This may prove to be a disadvantage when employing minimally invasive techniques that prolong the duration of CPB.

Key words:

Cardiopulmonary bypass - Haemostasis - Platelet function - Fibrinolysis - Coronary artery bypass grafting

References

  • 1 Puskas J D, Wright C E, Ronson R S, Brown III W W, Gott J P, Guyton R A. Off-pump multivessel coronary bypass via sternotomy is safe and effective.  Ann Thorac Surg. 1998;  66 1068-72
    CrossrefPubMedGoogle Scholar
  • 2 Cooley D A. Minimally invasive valve surgery versus the conventional approach.  Ann Thorac Surg. 1998;  66 1101-1105
    CrossrefPubMedGoogle Scholar
  • 3 Despotis G J, Filos K S, Zoys T N, Hogue C W, Spitznagel E, Lappas D G. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients.  Anesth Analg. 1996;  82 13-21
    PubMedGoogle Scholar
  • 4 Wahba A, Black G, Koksch M. et al . Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass.  Thrombosis and Haemostasis. 1996;  75 844-848
    PubMedGoogle Scholar
  • 5 Schmitz G, Rothe G, Ruf A. et al . European Working Group on Clinical Cell Analysis: Consensus Protocol for the flow cytometric characterisation of platelet function.  Thromb Haemost. 1998;  79 885-96
    PubMedGoogle Scholar
  • 6 Janes S L, Wilson D J, Cox A D. et al . ADP causes partial degranulation of platelets in the absence of aggregation.  Br J Haematol. 1994;  86 568-573
    PubMedGoogle Scholar
  • 7 Lefkovits J, Plow E F, Topol E J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine.  N Engl J Med. 1995;  332 1553-1559
    CrossrefPubMedGoogle Scholar
  • 8 Addo J B, Bray P F, Grigoryev D. et al . Surface recruitment but not activation of integrin alpha IIb beta 3 (GPIIb-IIIa) requires a functional actin cytoskeleton.  Arterioscler Thromb Vasc Biol. 1995;  15 1466-1473
    PubMedGoogle Scholar
  • 9 Michelson A D. Flow cytometry: A clinical test of platelet function.  Blood. 1996;  87 4925-4936
    PubMedGoogle Scholar
  • 10 Kestin A S, Shukri C R, Loscalzo J. et al . The platelet function defect of cardiopulmonary bypass.  Blood. 1993;  82 107-117
    PubMedGoogle Scholar
  • 11 Hunt B J, Parratt R N, Segal H C, Sheikh S, Kallis P, Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations.  Ann Thorac Surg. 1998;  65 712-718
    CrossrefPubMedGoogle Scholar
  • 12 Ereth M H, Nuttall G A, Oliver WC j r, Santrach P J, Price R D, Schaff H V. Temperature and duration of cardiopulmonary bypass influence transfusion requirements.  J Clin Anesth. 1998;  10 588-592
    CrossrefPubMedGoogle Scholar
  • 13 Kongsgaard U E, Smith-Erichsen N, Geiran O, Bjornskau L. Duration of cardiopulmonary bypass compared with changes in the plasma protease systems.  Scand J Thorac Cardiovasc Surg. 1991;  25 223-226
    PubMedGoogle Scholar
  • 14 Harker L A, Malpass T W, Branson H E, Hessel II E A, Slichter S J. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective α-granule release.  Blood. 1980;  56 824-834
    PubMedGoogle Scholar

Dr. med. Alexander WahbaPh. D., FETCS 

Hjerteklinikken St. Elisabeth

Hans Nissens gate 3

7018 Trondheim

Norway

Phone: +47-73867028

Fax: +47-73867029

Email: awahba@gmx.net

      >